Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
Mathieu Gendrot, Julien Andréani, Manon Boxberger, Priscilla Jardot, Isabelle Fonta, Marion Le Bideau, Isabelle Duflot, Joël Mosnier, Clara Rolland, Hervé Bogreau, Sébastien Hutter, Bernard La Scola, Bruno Pradines
Topics & Concepts
ArtesunateMefloquineLumefantrinePharmacologyPiperaquineDihydroartemisininEC50AmodiaquineHydroxychloroquineArtemetherMalariaMedicineArtemisininChloroquineTraditional medicinePlasmodium falciparumCoronavirus disease 2019 (COVID-19)VirologyBiologyIn vitroInternal medicineImmunologyInfectious disease (medical specialty)BiochemistryDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesMosquito-borne diseases and control